BioA Managing Director at Schooner Capital, Ted invests across asset classes, including venture and growth stage companies as well as alternative assets, with time allocated to internal management, asset allocation and firm strategy. Presently, he is a director at 4G Clinical, Cartesian Therapeutics, Eastern Point Capital, Millstone Medical Outsourcing, Nanoscale Powders, SHIFT, Spotted, SRS Medical, and Zixi. He has le ....
Access "Ted Henderson" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any)
in one connected platform (AcquityData).
We use essential cookies to run this site (like keeping you signed in), and — only with your consent — analytics cookies to understand how the site is used. See our
Privacy Policy for details on what we collect and why.